C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
a study on Diabetes Diabetes Type 1
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California
- Dates
- study startedstudy ends around
- Principal Investigator
- by Estelle Everett, MD, MHS
Description
Summary
The goal of this randomized study is to learn whether a CGM-guided insulin dosing education program can help adults with diabetes improve how they dose mealtime insulin. The main question it aims to answer is:
- Does CGM-guided insulin dosing education improve insulin dosing behaviors and glycemic outcomes in adults with diabetes who do not routinely use carbohydrate counting?
Participants will be randomly assigned to either the C-CARBS intervention or usual care. Participants will complete study visits, questionnaires, and meal and insulin logs, and CGM data will be collected to evaluate changes in insulin dosing behaviors and glycemic outcomes.
Official Title
A Novel Approach to Teaching Carb Awareness to Vulnerable Patients With Type 1 Diabetes
Details
The C-CARBS study is a randomized controlled study evaluating a patient-facing education program designed to help adults with diabetes use continuous glucose monitoring (CGM) data to guide mealtime insulin dosing. The study focuses on adults with diabetes who use CGM and multiple daily insulin injections (MDI) and who do not routinely use carbohydrate counting or have difficulty with carbohydrate counting.
Participants will be randomly assigned to either the C-CARBS intervention or usual care. Participants assigned to the intervention will receive four weekly, one-hour education sessions with a Certified Diabetes Care and Education Specialist. The sessions will focus on using CGM information, including current glucose levels and glucose trends, to support mealtime insulin dosing without relying solely on traditional carbohydrate counting.
Participants in both groups will complete study assessments throughout the study, including questionnaires and four 3-day meal and insulin logs. Meal and insulin information may be recorded manually or through the participant's Dexcom app. CGM data and laboratory measures, including hemoglobin A1c (HbA1c), will be collected to evaluate changes in glycemic outcomes. The study will also assess participants' insulin dosing behaviors, use of diabetes technology, and experience with the intervention.
The primary goal of the study is to determine whether the C-CARBS education program can improve mealtime insulin dosing behaviors and glycemic outcomes among adults with diabetes who do not routinely use carbohydrate counting.
Keywords
Type 1 Diabetes, Diabetes, Carbohydrate Counting, CGM, Type 1 Diabetes Mellitus, Diabetes Mellitus, C-Carbs Program
Eligibility
You can join if…
Open to people ages 18 years and up
- Adults 18 years of age or older.
- Diagnosis of diabetes for at least 1 year.
- Currently using or willing to start using a continuous glucose monitor (CGM).
- Currently using multiple daily insulin injections (MDI).
- HbA1c ≥8% at screening/baseline.
- Does not routinely use carbohydrate counting or demonstrates poor/inconsistent carbohydrate counting for mealtime insulin dosing.
- Able and willing to participate in the study visits and intervention sessions.
- Able to provide informed consent.
You CAN'T join if...
- Use of an insulin pump or automated insulin delivery system.
- Significant medical, cognitive, or psychiatric condition that, in the investigator's judgment, would interfere with participation or completion of study procedures.
Limited life expectancy that would prevent completion of the study.
- Pregnancy or plans to become pregnant during the study period.
- Current participation in another interventional study that could affect diabetes management or study outcomes.
- Inability/unwillingess to independently use a CGM device or administer insulin.
- Any other condition that, in the investigator's judgment, would make participation inappropriate or interfere with the study's objectives.
Location
- University of California Los Angeles
accepting new patients
Los Angeles California 90095 United States
Lead Scientist at UCLA
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Los Angeles
- Links
- Sign up for this study
- ID
- NCT07807280
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated
Please contact me about this study
We will not share your information with anyone other than the team in charge of this study, which might include an external sponsor. Providing your contact details does not obligate you to participate in the research.
Thank you!
The study team should get back to you in a few business days.